Oramed extends Scilex payment obligations; receives $0.5M, $5M due July 31

ORAMED PHARMACEUTICALS INC.

Scilex owes ~$29.5M on Tranche A Note and ~$6.7M on Tranche B Note amortization as of June 30, 2026.
Extension agreement: Scilex pays $0.5M (received), $5M by July 31, 2026, balance by Sept 30, 2026.
First $1M received is extension fee; if Scilex fails by Sept 30, first $1.5M becomes non-refundable fee.
If Scilex defaults, remaining obligations may be satisfied via delivery of Scilex common shares.
Bylaws amended to revise record date procedures for stockholder action by written consent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.